Leadership in Etch and DepositionWide moat

Lam Research (LRCX) — moat facet

Lam's tools do the steps that multiply as chips are stacked and shrunk, which is why its market grows faster than the number of wafers.

Lam makes the machines that add and remove material on a silicon wafer. Its 10-K describes the business as supplying "wafer fabrication equipment and services" and claims "leadership and expertise in deposition", etch and clean markets1. Its results releases put it more simply: "nearly every advanced chip is built with Lam technology"2.

Operating income ($M)788FY20153,213FY20184,482FY20214,264FY20248,200FY2026Lam Research XBRL filings (CF) and Form 10-K FY2026
Operating income ten times larger than in FY2015.

The reason those steps matter is the way chips are now made. Instead of shrinking features on a flat wafer, manufacturers stack memory cells in hundreds of layers and build transistors in three dimensions. The 10-K says these inflections are "increasing manufacturing complexity and precision requirements"3. Every added layer needs another deposition and another etch, so Lam's market per wafer grows even when wafer volumes do not.

The evidence of leadership is in the field and in the numbers. Management says Lam leads conductor etch with more than 40,000 chambers installed4. Systems revenue, sales of new leading-edge tools, rose 29.5% to $14,885.5 million in fiscal 20265, and the chief financial officer said Lam's served market was about 36% to 36.5% of 2026 wafer fab equipment spending6.

It is expensive to keep. Research and development was $2,375.9 million in fiscal 20267, and Lam plans to spend more than $3 billion over five years expanding its lab network8.

Two things keep this facet narrower than it looks. The rivals are strong and named in Lam's own filing: Applied Materials in deposition and etch, Tokyo Electron and Hitachi in etch, ASM International in atomic layer deposition9. And the market itself swings: revenue fell 14.5% in fiscal 202410.

The product range explains why one company can claim three markets. Beside the etch families, the 10-K lists SABRE, ALTUS, VECTOR and Striker in deposition, and EOS, DV-Prime, Da Vinci, SP Series and Coronus in clean11. Lam's fifth listed strength is its focus on delivering "multi-product solutions"12: selling several steps of the same process flow, which makes a Lam fab harder to split between suppliers.

Clean is the least discussed of the three markets and the one with the most specialised rivals: the 10-K names Screen, Semes and Tokyo Electron as primary competitors in wet clean13. Lam's clean families include the Coronus bevel clean line and single-wafer wet tools14, which ride along with its etch and deposition sales in the same fabs.

The facet holds as long as Lam keeps outgrowing its market. Management expects 2026 to be the third year in a row of relative outperformance15; a year in which Lam grows slower than wafer fab equipment spending would be the first evidence that the next inflections are being won by others.

Moat trajectory: Widening

Third straight year of outperformance against WFE; NAND layers and foundry both adding steps.

The number that tests this moat
Reported
Systems revenue growth, full year
+29.5% to $14,885.5M (FY2026)

New-tool sales against the market; growth below WFE growth for a year would mean inflections going elsewhere.

Source: Lam Research Form 10-K, FY2026 ↗
Aspects of the moat
⚠ Threats to the moat
References
  1. ReportedIts 10-K describes the business as supplying "wafer fabrication equipment and services" and claims "leadership and expertise in deposition", etch and clean markets.
    Lam Research Form 10-K for fiscal 2026 (year ended 28 June 2026) - Item 1 business: products, strategy, competitors, customers and employees. — FY2026 · publ. 7 August 2026 · source ↗
  2. ReportedIts results releases put it more simply: "nearly every advanced chip is built with Lam technology".
    Lam Research fourth-quarter fiscal 2026 results release, Form 8-K exhibit 99.1 - revenue, margins, revenue by type and region, cash flow and September 2026 quarter guidance. — Q4 FY2026 · publ. 29 July 2026 · source ↗
  3. ReportedThe 10-K says these inflections are "increasing manufacturing complexity and precision requirements".
    Lam Research Form 10-K for fiscal 2026 (year ended 28 June 2026) - Item 1 business: products, strategy, competitors, customers and employees. — FY2026 · publ. 7 August 2026 · source ↗
  4. ReportedManagement says Lam leads conductor etch with more than 40,000 chambers installed.
    The Motley Fool via Yahoo Finance, Lam Research Q4 fiscal 2026 earnings call transcript - installed base, end-market mix of systems revenue, WFE outlook, served market, customer support, China and margin targets - installed base, customer support, inventory, receivables and records. — Q4 FY2026 · publ. 29 July 2026 · source ↗
  5. ReportedSystems revenue, sales of new leading-edge tools, rose 29.5% to $14,885.5 million in fiscal 2026, and the chief financial officer said Lam's served market was about 36% to 36.5% of 2026 wafer fab equipment spending.
    Lam Research Form 10-K for fiscal 2026 (year ended 28 June 2026) - Item 7 MD&A and revenue notes: revenue by type, region and end market, and margins. — FY2026 · publ. 7 August 2026 · source ↗
  6. ReportedSystems revenue, sales of new leading-edge tools, rose 29.5% to $14,885.5 million in fiscal 2026, and the chief financial officer said Lam's served market was about 36% to 36.5% of 2026 wafer fab equipment spending.
    The Motley Fool via Yahoo Finance, Lam Research Q4 fiscal 2026 earnings call transcript - installed base, end-market mix of systems revenue, WFE outlook, served market, customer support, China and margin targets - wafer fab equipment outlook, served market, margins and growth targets. — Q4 FY2026 · publ. 29 July 2026 · source ↗
  7. ReportedResearch and development was $2,375.9 million in fiscal 2026, and Lam plans to spend more than $3 billion over five years expanding its lab network.
    Lam Research Form 10-K for fiscal 2026 (year ended 28 June 2026) - Item 1 business: products, strategy, competitors, customers and employees. — FY2026 · publ. 7 August 2026 · source ↗
  8. ReportedResearch and development was $2,375.9 million in fiscal 2026, and Lam plans to spend more than $3 billion over five years expanding its lab network.
    PR Newswire, Lam Research plans to invest more than $3 billion over the next five years to expand its global R&D lab network. — August 2026 · publ. 13 August 2026 · source ↗
  9. ReportedThe rivals are strong and named in Lam's own filing: Applied Materials in deposition and etch, Tokyo Electron and Hitachi in etch, ASM International in atomic layer deposition.
    Lam Research Form 10-K for fiscal 2026 (year ended 28 June 2026) - Item 1 business: competition and intellectual property. — FY2026 · publ. 7 August 2026 · source ↗
  10. Moat Explorer calcAnd the market itself swings: revenue fell 14.5% in fiscal 2024.
    Moat Explorer calculation from Lam Research's reported figures ($ millions unless stated; fiscal years end in late June). Revenue growth: FY2019 9,653.6 / 11,077.0 - 1 = -12.9%; FY2020 10,044.7 / 9,653.6 - 1 = +4.1%; FY2021 14,626.2 / 10,044.7 - 1 = +45.6%; FY2022 17,227.0 / 14,626.2 - 1 = +17.8%; FY2023 17,428.5 / 17,227.0 - 1 = +1.2%; FY2024 14,905.4 / 17,428.5 - 1 = -14.5%; FY2025 18,435.6 / 14,905.4 - 1 = +23.7%; revenue FY2015-FY2026 23,232.7 / 5,259.3 = 4.4 times. Q4 FY2026 revenue 6,722.2 / 5,171.4 - 1 = +30.0%; Q4 systems 4,249.8 / 3,437.6 - 1 = +23.6%; Q4 customer support 2,472.4 / 1,733.8 - 1 = +42.6%; FY2025 quarterly systems 3,437.6 / 2,392.7 - 1 = +43.7%. Revenue by type: systems FY2023 10,695.9 / 11,322.3 - 1 = -5.5%; FY2024 8,921.6 / 10,695.9 - 1 = -16.6%; customer support FY2023 6,732.6 / 5,904.8 - 1 = +14.0%; FY2024 5,983.7 / 6,732.6 - 1 = -11.1%, a fall of 748.9; FY2021 growth systems +47.4%, support +42.2%; FY2022 systems +16.0%, support +21.5%; FY2025 systems +28.8%, support +16.1%; FY2026 systems +29.5%, support +20.2%; support less systems growth -5.2, +5.5, +19.5, +5.5, -12.7, -9.3 points (FY2021-FY2026). Multiples FY2019-FY2026: customer support 8,347.2 / 3,202.5 = 2.6 times (14.7% a year); systems 14,885.5 / 6,451.1 = 2.3 times (12.7% a year). Cumulative FY2019-FY2026 customer support 45,396.0 of 125,553.6 = 36%. Customer support share of revenue: 3,202.5 / 9,653.6 = 33.2% (FY2019); 3,419.6 / 10,044.7 = 34.0%; 4,861.3 / 14,626.2 = 33.2%; 5,904.8 / 17,227.0 = 34.3%; 6,732.6 / 17,428.5 = 38.6%; 5,983.7 / 14,905.4 = 40.1% (FY2024); 6,944.3 / 18,435.6 = 37.7%; 8,347.2 / 23,232.7 = 35.9% (FY2026). Systems share 65.7%, 61.4%, 59.9%, 62.3%, 64.1% (FY2022-FY2026). Quarterly FY2026 support share 1,776.6 / 5,324.2 = 33.4%; 1,987.3 / 5,344.8 = 37.2%; 2,110.9 / 5,841.5 = 36.1%; 2,472.4 / 6,722.2 = 36.8%. Research and development 2,375.9 / 23,232.7 = 10.2% (FY2026); 825.2 / 5,259.3 = 15.7% (FY2015); 1,033.7 / 8,013.6 = 12.9% (FY2017); 1,191.3 / 9,653.6 = 12.3% (FY2019); 1,493.4 / 14,626.2 = 10.2% (FY2021); 1,727.2 / 17,428.5 = 9.9% (FY2023); 1,902.4 / 14,905.4 = 12.8% (FY2024); 2,375.9 / 825.2 = 2.9 times. Gross margin 2,284.3 / 5,259.3 = 43.4% (FY2015); 3,603.4 / 8,013.6 = 45.0% (FY2017); 4,358.5 / 9,653.6 = 45.1% (FY2019); 6,805.3 / 14,626.2 = 46.5% (FY2021); 7,776.9 / 17,428.5 = 44.6% (FY2023); 7,052.8 / 14,905.4 = 47.3% (FY2024). Operating margin 788.0 / 5,259.3 = 15.0% (FY2015); 1,902.1 / 8,013.6 = 23.7%; 2,464.7 / 9,653.6 = 25.5%; 4,482.0 / 14,626.2 = 30.6%; 5,174.9 / 17,428.5 = 29.7%; 4,263.9 / 14,905.4 = 28.6% (FY2024). Segment gross margin 12,120.0 / 23,232.7 = 52.2%. Region FY2026: China 7,859.8 / 23,232.7 = 33.8%; Taiwan 5,222.9 / 23,232.7 = 22.5%; Korea 4,505.3 / 23,232.7 = 19.4%; Japan 2,171.1 / 23,232.7 = 9.3%; Taiwan 5,222.9 / 3,445.2 - 1 = +51.6%; Korea 2,874.0 / 4,037.5 - 1 = -28.8%. China share 1,040.0 / 5,885.9 = 17.7% (FY2016); 1,784.4 / 11,077.0 = 16.1% (FY2018); 3,083.9 / 10,044.7 = 30.7% (FY2020); 5,137.9 / 14,626.2 = 35.1% (FY2021); 4,462.7 / 17,428.5 = 25.6% (FY2023). China revenue FY2022-FY2023 5,411.5 - 4,462.7 = 948.8 lower. Foundry plus memory 54 + 39 = 93%. Long-lived assets in the United States 2,003.4 / 3,353.8 = 60%. Customer concentration (percentages of total revenue): FY2026 16 + 15 + 12 + 12 = 55%; FY2025 17 + 15 = 32%; FY2024 17%; FY2023 22 + 16 = 38%; FY2022 21 + 12 + 12 + 11 = 56%; FY2021 25 + 12 + 10 = 47%; FY2020 24 + 14 + 10 + 10 = 58%; FY2019 15 + 14 + 14 + 14 = 57%; FY2018 25 + 14 + 14 + 13 + 12 = 78%. Accounts receivable June 2026 20 + 16 + 15 + 11 + 10 = 72%. Deferred revenue within a year 1,798.1 / 2,434.0 = 74%; deferred revenue against Q4 revenue 2,434.0 / 6,722.2 = 36%. Cash and capital: free cash flow 5,857.7 - 966.4 = 4,891.3 (FY2026); 6,173.3 - 759.2 = 5,414.1 (FY2025); 4,652.3 - 396.7 = 4,255.6 (FY2024). Shareholder returns 3,851.3 + 1,270.6 = 5,121.9, 5,121.9 / 4,891.3 = 104.7%; FY2025 (3,422.3 + 1,149.5) / 5,414.1 = 84.4%; FY2024 (2,842.8 + 1,018.9) / 4,255.6 = 90.7%. Dividends 1,270.6 / 7,265.4 = 17.5% of net income; 1,270.6 / 4,891.3 = 26% of free cash flow. Net cash 5,579.2 - 3,722.1 = 1,857.1 (FY2026); 6,390.7 - 4,469.4 = 1,921.3 (FY2025); 5,847.9 - 4,967.4 = 880.5 (FY2024). Treasury stock 31,597.9 / retained earnings 34,950.3 = 0.90. Per share: diluted shares 1,261.1 / 1,770.7 - 1 = -28.8% (FY2015 177.07M pre-split x 10); EPS 5.76 / 0.37 = 15.6 times; net income 7,265.4 / 655.6 = 11.1 times. Additional: Taiwan share 1,671.8 / 14,905.4 = 11.2% (FY2024), 3,477.9 / 17,428.5 = 20.0% (FY2023); Korea 2,205.3 / 3,832.8 - 1 = -42% (FY2019); research growth 2,096.4 / 1,902.4 - 1 = +10.2% (FY2025), 2,375.9 / 2,096.4 - 1 = +13.3% (FY2026); research staff 23,300 x 26% = more than 6,000; United States and Southeast Asia (1,528.9 + 1,245.9) / 23,232.7 = 12.0%; Southeast Asia 1,245.9 / 837.2 - 1 = +48.8%; systems FY2020 6,625.1 / 6,451.1 - 1 = +2.7%, support 3,419.6 / 3,202.5 - 1 = +6.8%; FY2022 to FY2025 support 6,944.3 / 5,904.8 - 1 = +17.6%, systems 11,491.3 / 11,322.3 - 1 = +1.5%; support March 2025 quarter 1,684.9 / 4,720.2 = 35.7%, 2,472.4 / 1,684.9 - 1 = +46.7%; support Q1 to Q4 FY2026 2,472.4 / 1,776.6 - 1 = +39.2%; deferred revenue 2,681 - 2,434 = 247 lower, 2,681 / 5,171.4 = 52% of the June 2025 quarter revenue; receivables 5,339.7 / 6,722.2 = 79%; return on equity 5,358.2 / ((8,539.5 + 9,861.6) / 2) = 58.2% (FY2025), 7,265.4 / ((9,861.6 + 12,470.9) / 2) = 65.1% (FY2026); market value 57.32 / 101.26 - 1 = -43% (calendar 2022); price target 373.13 / 307.16 - 1 = +21%; revenue 23,232.7 / 4,607.3 = 5.0 times (FY2014-FY2026); lab plan 3,000 / 5 = 600 a year. Further: Europe 698.7 / 23,232.7 = 3.0%; China 7,859.8 / 623.4 = 12.6 times (FY2014-FY2026); Korea 4,505.3 / 1,127.4 = 4.0 times; Taiwan 5,222.9 / 1,049.2 = 5.0 times; dividends declared per share 0.92 / 0.80 - 1 = +15%, 1.04 / 0.92 - 1 = +13%; diluted shares (1,261.1 / 1,319.9) ^ (1/2) - 1 = -2.3% a year; buybacks FY2015-FY2026 573.2 + 158.4 + 811.7 + 2,653.2 + 3,780.6 + 1,369.6 + 2,697.7 + 3,865.7 + 2,017.0 + 2,842.8 + 3,422.3 + 3,851.3 = 28,043.5; dividends paid 116.1 + 190.4 + 243.5 + 307.6 + 678.3 + 656.8 + 727.0 + 815.3 + 907.9 + 1,018.9 + 1,149.5 + 1,270.6 = 8,081.9; net income FY2015-FY2026 = 39,567.4; (28,043.5 + 8,081.9) / 39,567.4 = 91%; customer support fell only in FY2024 among FY2020-FY2026, systems fell in FY2023 and FY2024. Cash conversion: operating cash flow / net income 6,173.3 / 5,358.2 = 115% (FY2025); 5,857.7 / 7,265.4 = 81% (FY2026). Valuation: price 307.16 / 52-week high 438.50 - 1 = -30.0%; free cash flow yield 4,891.3 / 384,360 = 1.3%; P/E 384,360 / 7,265.4 = 52.9; P/S 384,360 / 23,232.7 = 16.5 - growth rates, margins and revenue by type. — FY2015-FY2026 · publ. September 2026 · source ↗
    Method: Arithmetic on figures reported in Lam Research's Forms 10-K, quarterly results releases, XBRL filings and market data; operands shown in the source line.
  11. ReportedBeside the etch families, the 10-K lists SABRE, ALTUS, VECTOR and Striker in deposition, and EOS, DV-Prime, Da Vinci, SP Series and Coronus in clean.
    Lam Research Form 10-K for fiscal 2026 (year ended 28 June 2026) - Item 1 business: products, strategy, competitors, customers and employees. — FY2026 · publ. 7 August 2026 · source ↗
  12. ReportedLam's fifth listed strength is its focus on delivering "multi-product solutions": selling several steps of the same process flow, which makes a Lam fab harder to split between suppliers.
    Lam Research Form 10-K for fiscal 2026 (year ended 28 June 2026) - Item 1 business: products, strategy, competitors, customers and employees. — FY2026 · publ. 7 August 2026 · source ↗
  13. ReportedClean is the least discussed of the three markets and the one with the most specialised rivals: the 10-K names Screen, Semes and Tokyo Electron as primary competitors in wet clean.
    Lam Research Form 10-K for fiscal 2026 (year ended 28 June 2026) - Item 1 business: competition and intellectual property. — FY2026 · publ. 7 August 2026 · source ↗
  14. ReportedLam's clean families include the Coronus bevel clean line and single-wafer wet tools, which ride along with its etch and deposition sales in the same fabs.
    Lam Research Form 10-K for fiscal 2026 (year ended 28 June 2026) - Item 1 business: products, strategy, competitors, customers and employees. — FY2026 · publ. 7 August 2026 · source ↗
  15. ReportedManagement expects 2026 to be the third year in a row of relative outperformance; a year in which Lam grows slower than wafer fab equipment spending would be the first evidence that the next inflections are being won by others.
    The Motley Fool via Yahoo Finance, Lam Research Q4 fiscal 2026 earnings call transcript - installed base, end-market mix of systems revenue, WFE outlook, served market, customer support, China and margin targets - wafer fab equipment outlook, served market, margins and growth targets. — Q4 FY2026 · publ. 29 July 2026 · source ↗
Sources
Generated September 25, 2026